Guidelines for laboratory diagnosis of factor XIII deficiency

Blood Coagulation and Fibrinolysis

Volumn 27, Issue 4, 2016, Pages 361-364

  Dorgalaleh, Akbar ^a   Tabibian, Shadi ^b   Hosseini, Soudabeh ^a   Shamsizadeh, Morteza ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHROUD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

factor XIII deficiency; guidelines; laboratory diagnosis

Indexed keywords

BLOOD CLOTTING FACTOR 13; COAGULATING AGENT; FIBRINOLYTIC AGENT;

ALGORITHM; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HUMAN; LABORATORY; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SCREENING; SOLUBILITY; BIOASSAY; BLOOD; DRUG EFFECTS; FACTOR XIII DEFICIENCY; FIBRINOLYSIS; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; UTILIZATION;

ALGORITHMS; BIOLOGICAL ASSAY; BLOOD COAGULATION TESTS; COAGULANTS; EARLY DIAGNOSIS; FACTOR XIII; FACTOR XIII DEFICIENCY; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; GENE EXPRESSION; GUIDELINES AS TOPIC; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 84947751786     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000459     Document Type: Review

References (23)

1. Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, Eshghi P. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost 2015; 41:323-329.
2. Naderi M, Dorgalaleh A, Tabibian S, Alizadeh S, Eshghi P, Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Pediatr Hematol Oncol 2013; 3:164-172.
3. Lawrie A, Green L, Mackie I, Liesner R, Machin S, Peyvandi F. Factor XIII - an under diagnosed deficiency - are we using the right assays? J Thromb Haemost 2010; 8:2478-2482.
4. Dorgalaleh A, Naderi M, Shamsizadeh M. Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol 2016; 95:451-455.
5. Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, et al. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol 2014; 100:443-449.
6. Poudyal BS, Shrestha GS. Factor XIII deficiency: the first case reported from Nepal. Egypt J Haematol 2015; 40:148.
7. Shanbhag S, Shetty S, Kulkarni B,Ghosh K. An improved, semi quantitative clot based assay for factor XIII. Haemophilia 2011; 17:718-720.
8. Perez DL, Diamond EL, Castro CM, Diaz A, Buonanno F, Nogueira RG, et al. Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: a case and literature review. Clin Neurol Neurosurg 2011; 113:142-145.
9. Dorgalaleh A, Farshi Y, Alizadeh S, Naderi M, Tabibian S, Kazemi A, et al. Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost 2015; 13:1735-1736.
10. Anwar R, Gallivan L, Miloszewski KJ, Markham AF. Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene. Thromb Haemost 2000; 84:591-594.
11. Anwar R, Gallivan L, Richards M, Khair K, Wright M, Minford A. Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene. Haematologica 2005; 90:1718-1720.
12. Ivaskevicius V, Seitz R, Kohler HP, Schroeder V, Muszbek L, Ariens RA, et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97:914-921.
13. Mikkola H, Yee VC, Syrjala M, Seitz R, Egbring R, Petrini P, et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 1996; 87:141-151.
14. Mikkola H, Syrjala M, Rasi V, Vahtera E, Hamalainen E, Peltonen L, et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point. Blood 1994; 84:517-525.
15. Mikkola H, Muszbek L, Haramura G, Hamalainen E, Jalanko A, Palotie A. Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins. Thromb Haemost 1997; 77:1068-1072.
16. Vysokovsky A, Saxena R, Landau M, Zivelin A, Eskaraev R, Rosenberg N, et al. Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2004; 2:1790-1797.
17. El Mahmoudi H, Amor M, Gouider E, Horchani R, Hafsia R, Fadhlaoui K, et al. Small insertion (c. 869insC) within F13A gene is dominant in Tunisian patients with inherited FXIII deficiency due to ancient founder effect. Haemophilia 2009; 15:1176-1179.
18. Louhichi N, Medhaffar M, HadjSalem I, Mkaouar-Rebai E, Fendri-Kriaa N, Kanoun H, et al. Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect. Ann Hematol 2010; 89:499-504.
19. Kulkarni BP, Nair SB, Vijapurkar M, Mota L, Shanbhag S, Ali S, et al. Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review. PLoS One 2014; 9:e108683.
20. Dorgalaleh A, Tabibian S, Hosseini M, Farshi Y, Roshan Zamir F, Naderi M, et al. Diagnosis of factor XIII deficiency. Hematology 2016; 5:1-27.
21. Jennings I, Kitchen S, Woods T, Preston F. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003; 1:2603-2608.
22. Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost 1995.
23. Kohler H, Ichinose A, Seitz R, Ariens R, Muszbek L. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9:1404-1406.